Skip to main content
SpringerLink
Log in

Novel AR-V7 detection in whole blood samples in patients with prostate cancer: not as simple as it seems

  • Letter to the Editor
  • Published:
World Journal of Urology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Watson PA, Arora VK, Sawyers CL (2015) Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer 15:701–711. doi:10.1038/nrc4016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Hegemann M, Stenzl A, Bedke J et al (2016) Liquid biopsy: ready to guide therapy in advanced prostate cancer? BJU Int 118:855–863. doi:10.1111/bju.13586

    Article  CAS  PubMed  Google Scholar 

  3. Antonarakis ES, Lu C, Wang H et al (2014) AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. N Engl J Med 371:1028–1038. doi:10.1056/NEJMoa1315815

    Article  PubMed  PubMed Central  Google Scholar 

  4. Antonarakis ES, Lu C, Luber B et al (2015) Androgen receptor splice variant 7 and efficacy of taxane chemotherapy in patients with metastatic castration-resistant prostate cancer. JAMA Oncol. doi:10.1001/jamaoncol.2015.1341

    PubMed  PubMed Central  Google Scholar 

  5. Steinestel J, Luedeke M, Arndt A, et al (2015) Detecting predictive androgen receptor modifications in circulating prostate cancer cells. Oncotarget. doi:10.18632/oncotarget.3925

    PubMed  PubMed Central  Google Scholar 

  6. Onstenk W, Onstenk W, Sieuwerts AM et al (2015) Efficacy of cabazitaxel in castration-resistant prostate cancer is independent of the presence of AR-V7 in circulating tumor cells. Eur Urol. doi:10.1016/j.eururo.2015.07.007

    PubMed  Google Scholar 

  7. Scher HI, Lu D, Schreiber NA et al (2016) Association of AR-V7 on circulating tumor cells as a treatment-specific biomarker with outcomes and survival in castration-resistant prostate cancer. JAMA. Oncol. doi:10.1001/jamaoncol.2016.1828

    Google Scholar 

  8. Liu X, Ledet E, Li D et al (2016) A whole blood assay for AR-V7 and AR(v567es) in patients with prostate cancer. J Urol 196:1758–1763. doi:10.1016/j.juro.2016.06.095

    Article  CAS  PubMed  Google Scholar 

  9. Qu F, Xie W, Nakabayashi M et al (2016) Association of AR-V7 and prostate specific antigen RNA levels in blood with efficacy of abiraterone acetate and enzalutamide treatment in men with prostate cancer. Clin Cancer Res. doi:10.1158/1078-0432.CCR-16-1070

    PubMed  Google Scholar 

  10. Todenhöfer T, Azad A, Stewart C et al (2016) AR-V7 transcripts in whole blood RNA of patients with metastatic castration resistant prostate cancer correlate with response to Abiraterone acetate. J Urol 197:135–142. doi:10.1016/j.juro.2016.06.094

    Article  PubMed  Google Scholar 

  11. Takeuchi T, Okuno Y, Hattori-Kato M et al (2016) Detection of AR-V7 mRNA in whole blood may not predict the effectiveness of novel endocrine drugs for castration-resistant prostate cancer. Res Rep Urol 8:21–25. doi:10.2147/RRU.S98877

    PubMed  PubMed Central  Google Scholar 

  12. Pantel K, Alix-Panabieres C (2015) Functional studies on viable circulating tumor cells. Clin Chem. doi:10.1373/clinchem.2015.242537

    PubMed Central  Google Scholar 

  13. de Wit S, van Dalum G, Lenferink ATM, et al (2015) The detection of EpCAM(+) and EpCAM(−) circulating tumor cells. Sci Rep 5:12270. doi:10.1038/srep12270

    Article  PubMed  PubMed Central  Google Scholar 

  14. Del Re M, Biasco E, Crucitta S et al (2016) The detection of androgen receptor splice variant 7 in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer patients. Eur Urol. doi:10.1016/j.eururo.2016.08.012

    PubMed  Google Scholar 

  15. Fleige S, Walf V, Huch S et al (2006) Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 28:1601–1613. doi:10.1007/s10529-006-9127-2

    Article  CAS  PubMed  Google Scholar 

  16. Kim SH, Park WS, Lee SJ, et al (2015) The quantified level of circulating prostate stem cell antigen mRNA relative to GAPDH level is a clinically significant indictor for predicting biochemical recurrence in prostate cancer patients after radical prostatectomy. Biomed Res Int 2015:292454. doi:10.1155/2015/292454

    PubMed  PubMed Central  Google Scholar 

  17. Ma Y, Luk A, Young FP et al (2016) Droplet digital PCR based androgen receptor variant 7 (AR-V7) detection from prostate cancer patient blood biopsies. Int J Mol Sci. doi:10.3390/ijms17081264

    Google Scholar 

  18. Qu Y, Dai B, Ye D, et al (2015) Constitutively active AR-V7 plays an essential role in the development and progression of castration-resistant prostate cancer. Sci Rep 5:7654. doi:10.1038/srep07654

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Yu Z, Yu Z, Chen S et al (2014) Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer. Clin Cancer Res 20:1590–1600. doi:10.1158/1078-0432.CCR-13-1863

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Robinson D, Robinson D, Van Allen EM et al (2015) Integrative clinical genomics of advanced prostate cancer. Cell 161:1215–1228. doi:10.1016/j.cell.2015.05.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Guedes LB, Morais CL, Almutairi F et al (2016) Analytic validation of RNA in situ hybridization (RISH) for AR and AR-V7 expression in human prostate cancer. Clin Cancer Res. doi:10.1158/1078-0432.CCR-16-0205

    PubMed  PubMed Central  Google Scholar 

  22. Antonarakis ES, Luo J (2016) Blood based detection of androgen receptor splice variants in. J Urol. doi:10.1016/j.juro.2016.09.001

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinic of Urology, University Hospital, Muenster, Germany

    Christof Bernemann, Julie Steinestel, Martin Boegemann & Andres J. Schrader

Authors
  1. Christof Bernemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julie Steinestel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Boegemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andres J. Schrader
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christof Bernemann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bernemann, C., Steinestel, J., Boegemann, M. et al. Novel AR-V7 detection in whole blood samples in patients with prostate cancer: not as simple as it seems. World J Urol 35, 1625–1627 (2017). https://doi.org/10.1007/s00345-017-2024-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-017-2024-6

Keywords

Search

Navigation